Kazazian Asset Management Upped Alexion Pharmaceuticals (ALXN) Holding; Southern Company (SO) SI Decreased By 0.34%

November 28, 2017 - By Dolores Ford

Southern Company (NYSE:SO) had a decrease of 0.34% in short interest. SO’s SI was 21.70M shares in November as released by FINRA. Its down 0.34% from 21.78M shares previously. With 3.91M avg volume, 6 days are for Southern Company (NYSE:SO)’s short sellers to cover SO’s short positions. The SI to Southern Company’s float is 2.19%. About 4.16M shares traded or 4.52% up from the average. Southern Co (NYSE:SO) has risen 2.49% since November 28, 2016 and is uptrending. It has underperformed by 14.21% the S&P500.

Kazazian Asset Management Llc increased Alexion Pharmaceuticals Inc (ALXN) stake by 72.38% reported in 2017Q2 SEC filing. Kazazian Asset Management Llc acquired 2,823 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 11.63%. The Kazazian Asset Management Llc holds 6,723 shares with $818,000 value, up from 3,900 last quarter. Alexion Pharmaceuticals Inc now has $24.15B valuation. The stock rose 0.02% or $0.02 reaching $108.12 per share. About 1.74M shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since November 28, 2016 and is downtrending. It has underperformed by 34.82% the S&P500.

Among 18 analysts covering The Southern Company (NYSE:SO), 6 have Buy rating, 4 Sell and 8 Hold. Therefore 33% are positive. The Southern Company had 48 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, September 12 by Jefferies. The stock of Southern Co (NYSE:SO) earned “Buy” rating by Jefferies on Friday, March 3. As per Wednesday, July 19, the company rating was maintained by Jefferies. The company was maintained on Thursday, July 14 by Goldman Sachs. The firm earned “Buy” rating on Thursday, September 14 by Guggenheim. Jefferies maintained Southern Co (NYSE:SO) on Tuesday, June 6 with “Buy” rating. The company was maintained on Monday, September 26 by SunTrust. Citigroup maintained the shares of SO in report on Tuesday, October 3 with “Sell” rating. The rating was maintained by Bank of America on Tuesday, October 24 with “Underperform”. BMO Capital Markets maintained it with “Hold” rating and $5300 target in Wednesday, August 2 report.

The Southern Company is a holding company. The company has market cap of $51.68 billion. The Firm owns all of the stock of the traditional electric operating companies and the parent entities of Southern Power Company (Southern Power) and Southern Company Gas, and owns other direct and indirect subsidiaries. It has a 92.72 P/E ratio. The Company’s divisions include Gas distribution operations, Gas marketing services, Wholesale gas services, Gas midstream activities and All other.

Since June 12, 2017, it had 0 insider buys, and 3 sales for $3.96 million activity. Lantrip Mark sold $1.29M worth of stock or 25,000 shares. BEATTIE ART P sold $2.42 million worth of stock or 46,940 shares. 5,000 shares were sold by Daiss Ann P, worth $256,400.

Investors sentiment decreased to 1.16 in Q2 2017. Its down 0.01, from 1.17 in 2017Q1. It fall, as 60 investors sold Southern Co shares while 330 reduced holdings. 78 funds opened positions while 373 raised stakes. 520.53 million shares or 0.60% less from 523.66 million shares in 2017Q1 were reported. Reynders Mcveigh Mgmt Lc invested in 4,893 shares or 0.03% of the stock. Carnegie Asset Management Limited Com invested 0.26% of its portfolio in Southern Co (NYSE:SO). Mufg Americas Holdings owns 23,233 shares. Moreover, Blume Cap Mgmt has 0.02% invested in Southern Co (NYSE:SO). State Of Wisconsin Invest Board holds 0.21% in Southern Co (NYSE:SO) or 1.35 million shares. Royal State Bank Of Canada holds 0.05% or 1.83M shares. Andra Ap reported 452,200 shares. Boys Arnold & reported 11,277 shares or 0.07% of all its holdings. Bancorpsouth owns 21,940 shares or 0.11% of their US portfolio. Abner Herrman And Brock Ltd Limited Liability Company invested in 9,138 shares. Blb&B Advsr Llc invested in 0.11% or 13,193 shares. Brown Advisory Securities Ltd Com invested in 0.07% or 6,347 shares. Southeast Asset Advisors Inc accumulated 0.41% or 26,434 shares. Carlson Cap L P holds 0.53% of its portfolio in Southern Co (NYSE:SO) for 778,400 shares. Pensionfund Dsm Netherlands reported 0.58% stake.

Since June 14, 2017, it had 4 buys, and 1 sale for $235.75 million activity. The insider PARVEN ALVIN S sold 835 shares worth $97,511. $156.92 million worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares were bought by BAKER BROS. ADVISORS LP. COUGHLIN CHRISTOPHER J bought $234,200 worth of stock or 2,000 shares. HANTSON LUDWIG bought 10,000 shares worth $1.17M.

Investors sentiment increased to 1.37 in Q2 2017. Its up 0.23, from 1.14 in 2017Q1. It increased, as 55 investors sold ALXN shares while 146 reduced holdings. 72 funds opened positions while 203 raised stakes. 208.01 million shares or 0.31% less from 208.67 million shares in 2017Q1 were reported. State Treasurer State Of Michigan holds 373,778 shares. Korea Inv Corporation has 0.06% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Meag Munich Ergo Kapitalanlagegesellschaft Mbh, a Germany-based fund reported 25,513 shares. Everence Inc accumulated 4,425 shares or 0.13% of the stock. Cambridge Investment Rech Advsrs Inc reported 0.01% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Federated Investors Pa invested in 0.22% or 630,864 shares. Ardsley Advisory Ptnrs accumulated 176,500 shares or 3.84% of the stock. 565,114 are held by Alliancebernstein L P. World Asset Mngmt, a Michigan-based fund reported 21,130 shares. Salem Counselors Inc stated it has 0% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Dimensional Fund Advsr Ltd Partnership reported 0.02% stake. Mason Street Ltd Limited Liability Company holds 0.09% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 31,166 shares. Rathbone Brothers Pcl, a United Kingdom-based fund reported 2,040 shares. Utd Automobile Association has 114,952 shares. Hap Trading Limited owns 110,847 shares.

Among 28 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Alexion Pharmaceuticals Inc. had 86 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by SunTrust given on Monday, October 23. The firm has “Outperform” rating given on Monday, July 11 by Credit Suisse. The company was maintained on Tuesday, August 15 by Oppenheimer. Wedbush maintained it with “Neutral” rating and $135 target in Friday, October 28 report. Cowen & Co maintained the stock with “Buy” rating in Thursday, July 27 report. The firm earned “Overweight” rating on Tuesday, June 7 by Morgan Stanley. The firm earned “Buy” rating on Tuesday, September 12 by Stifel Nicolaus. The company was maintained on Friday, July 29 by Stifel Nicolaus. BMO Capital Markets maintained the stock with “Buy” rating in Friday, July 21 report. On Friday, October 27 the stock rating was maintained by Stifel Nicolaus with “Buy”.